Abstract
Iliofemoral deep vein thrombosis is a common clinical condition which often results in post-thrombotic syndrome, a cause of long-term morbidity due to diminished function. The mainstays of treatment for deep vein thrombosis include anticoagulation and compression therapy but these only prevent propagation of the venous clot. Therapeutic options which actively remove clot decrease the risk of post-thrombotic syndrome when compared to conventional anticoagulation alone, an effect attributed to alleviated obstruction and decreased damage to venous valves. Removal of venous clot with catheter-directed thrombolysis is a safe, effective treatment option which can improve functional outcomes in iliofemoral deep vein thrombosis. In patients with contraindication to thrombolytic therapy, surgical thrombectomy is an alternative which also improves functional outcomes in iliofemoral deep vein thrombosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Browse NL, Burnand KG, Lea Thomas M. Deep vein thrombosis: pathology, diagnosis, and treatment. In: Browse NL, Burnand KG, Irvine AT, editors. Disease of the veins. 2nd ed. London: Edward Arnold; 1999. p. 443–74.
Mohr DN, Silverstein MD, Heit JA, et al. The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: a population-based study. Mayo Clin Proc. 2000;75:1249–56.
Brandjes DP, Buller HR, Heijboer H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet. 1997;349:759–62.
Saarinen J, Kallio T, Lehto M, et al. The occurence of the post-thrombotic changes after an acute deep venous thrombosis. A prospective two-year follow-up study. J Cardiovasc Surg. 2000;41:441–6.
Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1–7.
Kahn SR, Shrier I, Julian JA, et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med. 2008;149:698–707.
Bergqvist D, Jendteg S, Johansen L, et al. Cost of long-term complications of deep venous thrombosis of the lower extremities: an analysis of a defined patient population in Sweden. Ann Intern Med. 1997;126:454–7.
Smith JJ, Guest MG, Greenhalgh RM, et al. Measuring the quality of life in patients with venous ulcers. J Vasc Surg. 2000;31:642–9.
Ruckley CV. Socioeconomic impact of chronic venous insufficiency and leg ulcers. Angiology. 1997;48:67–9.
Suwanabol PA, Hoch JR. Venous thromboembolic disease. Surg Clin North Am. 2013;93:983–95.
Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:454S–545.
Prandoni P, Lensing AW, Prins MH, et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome. Ann Intern Med. 2004;141:249–56.
Kahn SR, Shapiro S, Wells PS, et al. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. Lancet. 2014;383:880–8.
Comerota AJ, Gale SS. Technique of contemporary iliofemoral and infrainguinal venous thrombectomy. J Vasc Surg. 2006;43:185–91.
Mewissen MW. Catheter-directed thrombolysis for lower extremity deep vein thrombosis. Tech Vasc Interv Radiol. 2001;4:111–4.
Soosainathan A, Moore HM, Gohel MS, et al. Scoring systems for the post-thrombotic syndrome. J Vasc Surg. 2013;57:254–61.
Okrent D, Messersmidt R, Buckman J. Transcatheter fibrinolytic therapy and angioplasty for left iliofemoral venous thrombosis. J Vasc Interv Radiol. 1991;1:195–7.
Bjarnason H, Kruse JR, Asinger DA, et al. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol. 1997;8:405–18.
Patel NH, Stookey KR, Ketcham DB, et al. Endovascular management of acute extensive iliofemoral deep venous thrombosis caused by May-Thurner syndrome. J Vasc Interv Radiol. 2000;11:1297–302.
Shortell CK, Queiroz R, Johansson M, et al. Safety and efficacy of limited-dose tissue plasminogen activator in acute vascular occlusion. J Vasc Surg. 2001;34:854–9.
Sugimoto K, Hofmann LV, Razavi MK, et al. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusion. J Vasc Surg. 2003;37:512–7.
Grunwald MR, Hofmann LV. Comparison of urokinase, alteplase, and reteplase for catheter-directed thombolysis of deep venous thrombosis. J Vasc Interv Radiol. 2004;15:347–52.
Mewissen MW, Seabrook GR, Meissner MH, et al. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology. 1999;211:39–49.
Kim HS, Preece SR, Black JH, et al. Safety of catheter-directed thrombolysis for deep venous thrombosis in cancer patients. J Vasc Surg. 2008;47:388–94.
Herrera S, Comerota AJ, Thakur S, et al. Managing iliofemoral deep venous thrombosis of pregnancy with a strategy of thrombus removal is safe and avoids post-thrombotic morbidity. J Vasc Surg. 2014;59:456–64.
Garg K, Cayne N, Jacobowitz G. Mechanical and pharmacologic catheter-directed thrombolysis treatment of severe, symptomatic, bilateral deep vein thrombosis with congenital absence of the inferior vena cava. J Vasc Surg. 2011;53:1707–10.
Sloot S, Nierop JV, Kootstra J, et al. Bilateral catheter-directed thombolysis in a patient with deep venous thrombosis caused by a hypoplastic inferior vena cava. Phlebology. 2015;30:293–5.
Meissner MH, Gloviczki P, Comerota AJ, et al. Early thrombus removal strategies for acute deep venous thrombosis: Clinical Practice Guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2012;55:1449–62.
Vedantham S, Thorpe PE, Cardella JF, et al. Quality improvement guidelines for the treatment of lower extremity deep vein thrombosis with use of endovascular thrombus removal. J Vasc Interv Radiol. 2009;20:S227–39.
Schweizer J, Kirch W, Koch R, et al. Short- and long-term results after thrombolytic treatment of deep venous thrombosis. J Am Coll Cardiol. 2000;36:1336–43.
Dasari TW, Pappy RM, Hennebry TA. Pharmacomechanical thrombolysis of acute and chronic symptomatic deep vein thrombosis: a systematic review of literature. Angiology. 2012;63:138–45.
Kim HS, Patra A, Paxton BE, et al. Adjunctive percutaneous mechanical thrombectomy for lower-extremity deep vein thrombosis: clinical and economic outcomes. J Vasc Interv Radiol. 2006;17:1099–104.
Lin PH, Zhou W, Dardik A, et al. Catheter-directed thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis. Am J Surg. 2006;192:782–8.
Casey ET, Murad MH, Zumaeta M, et al. Treatment of acute iliofemoral deep vein thrombosis. J Vasc Surg. 2012;55:1463–73.
Watson L, Broderick C, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev. 2014;(1):CD002783.
Comerota AJ, Throm RC, Mathias SD, et al. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg. 2000;32:130–7.
AbuRahma AF, Perkins SE, Wulu JT, et al. Iliofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting. Ann Surg. 2001;233:752–60.
Comerota AJ. Quality-of-life improvement using thrombolytic therapy for iliofemoral deep venous thrombosis. Rev Cardiovasc Med. 2002;3:S61–7.
Elsharawy M, Elzayat E. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomised clinical trial. Eur J Vasc Endovasc Surg. 2002;24:209–14.
Markevicius N, Apanavicius G, Scerbinskas S. Comparison between long-term results of catheter-directed thrombolysis and anticoagulation in the treatment of acute iliofemoral deep vein thrombosis. Phlebology. 2004;19:148–9.
Enden T, Haig Y, Klow NE, et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet. 2012;379:31–8.
Enden T, Wik HS, Kvam AK, et al. Health-related quality of life after catheter-directed thombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study. BMJ Open. 2013;3:e002984.
Baekgaard N. Benefit of catheter-directed thrombolysis for acute iliofemoral DVT: myth or reality? Eur J Vasc Endovasc Surg. 2014;48:361–2.
Vedantham S, Goldhaber SZ, Kahn ST, et al. Rationale and design of the ATTRACT study – a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of post-thrombotic syndromes in patients with proximal deep vein thrombosis. Am Heart J. 2013;165:523–30.
Sharafuddin MJ, Gu X, Han YM, et al. Injury potential to venous valves from the Amplatz thrombectomy device. J Vasc Interv Radiol. 1999;10:64–9.
Vedantham S, Vesely TM, Parti N, et al. Lower extremity venous thrombolysis with adjunctive mechanical thrombectomy. J Vasc Interv Radiol. 2002;13:1001–8.
Cakir V, Gulcu A, Akay E, et al. Use of percutaneous aspiration thrombectomy vs anticoagulation therapy to treat acute iliofemoral venous thrombosis: 1-year follow-up results of a randomised, clinical trial. Cardiovasc Interv Radiol. 2014;37:969–76.
Plate G, Eklof B, Norgren L, et al. Venous thrombectomy for iliofemoral vein thrombosis – 10-year results of a prospective randomised study. Eur J Vasc Endovasc Surg. 1997;14:367–74.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Patel, M.V., Funaki, B. (2017). In Patients with Iliofemoral Deep Vein Thrombosis Does Clot Removal Improve Functional Outcome When Compared to Traditional Anticoagulation?. In: Skelly, C., Milner, R. (eds) Difficult Decisions in Vascular Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach. Springer, Cham. https://doi.org/10.1007/978-3-319-33293-2_34
Download citation
DOI: https://doi.org/10.1007/978-3-319-33293-2_34
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33291-8
Online ISBN: 978-3-319-33293-2
eBook Packages: MedicineMedicine (R0)